Honasa Consumer

HONASA closed at ₹464.90 on 2026-11-06, following an extreme-volume downward move (-3.5%) after a +4.3% gap-up the prior day. The stock remains in a structural uptrend across daily, weekly, and monthly horizons, trading above all key moving averages and the Supertrend. However, daily trend strength is weak (ADX 13.63), contrasting with established momentum on weekly (ADX 34.98) and monthly (ADX 39.99) charts. Price sits in the upper-middle of its 20-day range (+65.5%) and near the top of its 252-day range (+82.8%), suggesting limited immediate upside room without a breakout. An active monthly Inside Bar pattern indicates consolidation, while current drawdown stands at -7.5% from highs. Key resistance lies at ₹467.50 (0.56% above) and ₹479.25 (3.09% above); support is found at ₹459.70 (1.12% below).

Honasa Consumer reported its Q2 FY27 results on November 6, 2026, marking the fastest revenue growth since its stock market debut. The company posted a 36% year-on-year increase in revenue to ₹731 crore and an 87% rise in net profit to ₹73 crore. This performance underscores a strategic transition from a single-brand reliance to a multi-platform model; younger brands such as The Derma Co. and Aqualogica grew by over 45%, contributing to focus categories that now account for more than 80% of total revenue. While Mamaearth remains profitable, the business mix has shifted significantly toward these newer entities. Operational expansion is evident through an offline retail network reaching approximately 3.2 lakh outlets. Management notes that sustaining this momentum depends on consumer demand, competitive conditions, and channel execution.

On November 6, 2026, Honasa Consumer reported unaudited financial results for Q2 FY27 (ended September 30, 2026), marking its fastest revenue growth since listing. Revenue surged 35.9% year-over-year to ₹731 crore, driven by over 45% growth in younger brands like The Derma Co. and Aqualogica, which now account for more than 80% of total revenue. This strategic shift away from a single-brand reliance has supported profitability: EBITDA nearly doubled to ₹93 crore (12.7% margin), and profit after tax rose 86.7% to ₹73 crore. For the half-year, revenue grew 31.2% to ₹1,487 crore with PAT increasing 103.2% to ₹164 crore.

Corporate developments included the recognition of a ₹978.07 million final dividend for FY2025-26 and the incorporation of Honasa Health Private Limited. Conversely, the company cancelled the proposed acquisition of Fluence Pharma Private Limited due to non-fulfillment of closing conditions. A monitoring agency report confirmed no deviation from IPO proceeds usage, noting that unutilized funds were placed in fixed deposits. On the same date, the stock price was recorded at ₹464.90, down from ₹481.75.

Honasa Consumer Limited reported unaudited financial results for Q2 and H1 FY2027 on November 6, 2026, highlighting significant operational expansion. Revenue from operations grew 35.9% year-over-year to INR 731 crore in Q2, with EBITDA nearly doubling to INR 93 crore (12.7% margin) and profit after tax rising 86.7% to INR 73 crore. For the half-year, revenue reached INR 1,487 crore (up 31.2%) and PAT increased to INR 164 crore (up 103.2%). The Board also approved a final dividend of Rs 978.07 million for FY2025-26.

Corporate governance updates include the cancellation of the proposed acquisition of Fluence Pharma Private Limited due to unfulfilled closing conditions, while Honasa Health Private Limited was incorporated. Additionally, a Scheme of Amalgamation between wholly-owned subsidiaries Bhabani Blunt Hair Dressing Private Limited and B:Blunt-Spratt Hairdressing Private Limited was approved on October 28, 2026, aimed at organizational simplification without altering the parent company's shareholding pattern. On the capital front, the company allotted 255,984 equity shares upon the exercise of vested employee stock options, increasing paid-up capital to ₹326,28,02,000.

Honasa Consumer demonstrates a robust recovery in profitability and cash generation, anchored by strong sequential growth in the first quarter of FY2026-27. Revenue from operations rose to ₹696.32 crore, up from ₹607.65 crore in Q4 FY2025-26, while Net Profit increased significantly to ₹84.31 crore from ₹64.47 crore. This improvement is reflected in Basic EPS, which climbed to ₹2.59 per share from ₹1.98. The company’s ability to convert earnings into cash remains a key quality indicator; historically, Cash Flow from Operations (CFO) has fluctuated, dropping to ₹102 crore in Mar 2025 before recovering to ₹141 crore in Mar 2026, with CFO/EBITDA declining from 194% to 85%, suggesting working capital dynamics are shifting.

On the balance sheet, Fixed Assets expanded sharply to ₹489 crore in Mar 2026 from ₹302 crore a year prior, indicating active capacity building or asset acquisition, supported by stable borrowings around ₹135–136 crore. Return on Capital Employed (ROCE) improved markedly to 19% in Mar 2026 from 8% in Mar 2025, signaling better efficiency in deploying capital. Shareholding patterns show increasing institutional confidence, with DIIs raising their stake to 23.37% in Sep 2026, while promoters maintained a steady ~35% holding. Finance costs remained controlled at ₹2.42 crore in Q1 FY2026-27. The primary checkpoint for investors is whether this margin expansion and asset utilization sustain as the company scales its fixed base.

Honasa Consumer demonstrated its strongest operational momentum since listing in Q2 FY27, with revenue surging 36% year-on-year to ₹731 crore and net profit jumping 87% to ₹73 crore. This growth is structurally supported by a successful diversification away from single-brand reliance; newer categories now contribute over 80% of total revenue, driven by more than 45% growth in younger brands like The Derma Co. and Aqualogica. Concurrently, the offline retail network has expanded to approximately 3.2 lakh outlets, providing tangible distribution scale. Technically, the stock exhibits bullish alignment across multiple timeframes, with the weekly Supertrend signaling an upward bias alongside strong positive directional movement (Plus DI at 22.9). While recent short-term returns have been mixed (-3.5% over one day), the broader trend remains positive (+67.9% over one year). Sustaining this constructive trajectory depends on maintaining consumer demand and competitive execution within this multi-platform model.

Honasa Consumer’s Q2 FY27 results show strong top-line growth, but the stock faces near-term technical resistance and elevated volatility. The share price closed at ₹464.90 on 2026-11-06, trading below its previous close of ₹481.75 and reflecting a -3.5% one-day return. Technical indicators highlight immediate overhead pressure, with a low-level resistance at ₹467.50 just 0.56% above current levels. The stock has experienced a maximum drawdown of -22.2% and currently sits in a -7.5% drawdown, supported by high annualized volatility of +36.9%. While momentum remains bullish on weekly and monthly timeframes, the daily trend shows a negative 50-day simple moving average slope of -2.01, suggesting shorter-term weakness despite longer-term gains.